ALGS
Closed
Aligos Therapeutics inc
7.39
+0.18 (+2.50%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 7.21
Day's Range: 6.8242 - 7.42
Send
sign up or login to leave a comment!
When Written:
0.874
Aligos Therapeutics Inc is a clinical-stage biotechnology company that focuses on developing treatments for viral infections and liver diseases. The company's lead product candidates are designed to target chronic hepatitis B virus (HBV) and COVID-19. Aligos Therapeutics uses a proprietary technology platform to develop small molecule drugs that target specific viral proteins and enzymes. The company is headquartered in South San Francisco, California, and was founded in 2018. Aligos Therapeutics has partnerships with several pharmaceutical companies and research institutions to advance its drug development programs.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








